Burwell Cautions Against Changing FDA Standards, Recommends Cybersecurity Investment
Executive Summary
As one potential candidate for FDA commissioner has called for dismissing efficacy requirements to approve products, Burwell, soon before relinquishing her role as HHS secretary, told reporters that safety trials are insufficient to prove true safety and that her successor at HHS should prioritize cybersecurity.